Cargando…

Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours

Canine mammary carcinoma represents a model for the study of human breast cancer, although the prognostic value of various clinical, histological and immunohistochemical parameters has shown contradictory results. A prospective study, through a 4‐year follow‐up, was performed in 77 patients with mam...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastor, Nieves, Ezquerra, Luis Javier, Santella, Massimo, Caballé, Nuria C., Tarazona, Raquel, Durán, María Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754150/
https://www.ncbi.nlm.nih.gov/pubmed/32336005
http://dx.doi.org/10.1111/vco.12603
_version_ 1783626136630067200
author Pastor, Nieves
Ezquerra, Luis Javier
Santella, Massimo
Caballé, Nuria C.
Tarazona, Raquel
Durán, María Esther
author_facet Pastor, Nieves
Ezquerra, Luis Javier
Santella, Massimo
Caballé, Nuria C.
Tarazona, Raquel
Durán, María Esther
author_sort Pastor, Nieves
collection PubMed
description Canine mammary carcinoma represents a model for the study of human breast cancer, although the prognostic value of various clinical, histological and immunohistochemical parameters has shown contradictory results. A prospective study, through a 4‐year follow‐up, was performed in 77 patients with mammary carcinoma to analyse the association between histological diagnosis, grade of malignancy, peritumoral and vascular invasion. We have also performed immunohistochemistry for the expression of oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and cyclooxygenase‐2 (COX‐2) that define human biomarkers of disease progression and treatment response. An association between histological diagnosis and clinical stage was observed with a high proportion of complex carcinoma classified as stage I. There was a higher proportion of ER(+)/PR(+)/HER2(−) tumours in stage I. In contrast, triple‐negative tumours (ER(−)/PR(−)/HER2(−)) were found mainly in advanced clinical stages and were associated with vascular and peritumoral invasion. The tumours included in group VII (carcinosarcoma/adenosquamous carcinoma/other special types of carcinoma) had a higher expression of COX‐2. The univariate analysis showed that those patients with complex carcinoma had the lowest incidence of metastases and the highest probability of survival. In contrast, a high proportion of patients with anaplastic/inflammatory carcinoma developed metastases and showed the lowest probability of survival. In addition, the estimated survival time was shorter for those patients with triple‐negative tumours and those with high COX‐2 expression. However, in the multivariate analysis, only the peritumoral invasion maintained its prognostic significance. In conclusion, in our study anaplastic/inflammatory carcinomas had the worst prognosis with a high proportion of triple‐negative tumours in this category.
format Online
Article
Text
id pubmed-7754150
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-77541502020-12-23 Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours Pastor, Nieves Ezquerra, Luis Javier Santella, Massimo Caballé, Nuria C. Tarazona, Raquel Durán, María Esther Vet Comp Oncol Original Articles Canine mammary carcinoma represents a model for the study of human breast cancer, although the prognostic value of various clinical, histological and immunohistochemical parameters has shown contradictory results. A prospective study, through a 4‐year follow‐up, was performed in 77 patients with mammary carcinoma to analyse the association between histological diagnosis, grade of malignancy, peritumoral and vascular invasion. We have also performed immunohistochemistry for the expression of oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and cyclooxygenase‐2 (COX‐2) that define human biomarkers of disease progression and treatment response. An association between histological diagnosis and clinical stage was observed with a high proportion of complex carcinoma classified as stage I. There was a higher proportion of ER(+)/PR(+)/HER2(−) tumours in stage I. In contrast, triple‐negative tumours (ER(−)/PR(−)/HER2(−)) were found mainly in advanced clinical stages and were associated with vascular and peritumoral invasion. The tumours included in group VII (carcinosarcoma/adenosquamous carcinoma/other special types of carcinoma) had a higher expression of COX‐2. The univariate analysis showed that those patients with complex carcinoma had the lowest incidence of metastases and the highest probability of survival. In contrast, a high proportion of patients with anaplastic/inflammatory carcinoma developed metastases and showed the lowest probability of survival. In addition, the estimated survival time was shorter for those patients with triple‐negative tumours and those with high COX‐2 expression. However, in the multivariate analysis, only the peritumoral invasion maintained its prognostic significance. In conclusion, in our study anaplastic/inflammatory carcinomas had the worst prognosis with a high proportion of triple‐negative tumours in this category. Blackwell Publishing Ltd 2020-05-22 2020-12 /pmc/articles/PMC7754150/ /pubmed/32336005 http://dx.doi.org/10.1111/vco.12603 Text en © 2020 The Authors. Veterinary and Comparative Oncology published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Pastor, Nieves
Ezquerra, Luis Javier
Santella, Massimo
Caballé, Nuria C.
Tarazona, Raquel
Durán, María Esther
Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
title Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
title_full Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
title_fullStr Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
title_full_unstemmed Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
title_short Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
title_sort prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754150/
https://www.ncbi.nlm.nih.gov/pubmed/32336005
http://dx.doi.org/10.1111/vco.12603
work_keys_str_mv AT pastornieves prognosticsignificanceofimmunohistochemicalmarkersandhistologicalclassificationinmalignantcaninemammarytumours
AT ezquerraluisjavier prognosticsignificanceofimmunohistochemicalmarkersandhistologicalclassificationinmalignantcaninemammarytumours
AT santellamassimo prognosticsignificanceofimmunohistochemicalmarkersandhistologicalclassificationinmalignantcaninemammarytumours
AT caballenuriac prognosticsignificanceofimmunohistochemicalmarkersandhistologicalclassificationinmalignantcaninemammarytumours
AT tarazonaraquel prognosticsignificanceofimmunohistochemicalmarkersandhistologicalclassificationinmalignantcaninemammarytumours
AT duranmariaesther prognosticsignificanceofimmunohistochemicalmarkersandhistologicalclassificationinmalignantcaninemammarytumours